NIO, Vertiv Rise; RH Moves Higher on Tariffs
On this episode of stock movers: NIO (NIO) shares rise after the EV-maker reported deliveries for December that showed 33% growth month-over-month. RH (RH) shares rise after President Donald Trump de...
2 Tammi 4min
Tesla Rises Ahead of Deliveries Report; BYD Sales Tops Tesla; Furniture Companies Move Higher
On this episode of Stock Movers:- Shares of Tesla (TSLA) outperformed Magnificent Seven shares in premarket trading ahead of the electric-car maker’s fourth-quarter production and deliveries report. E...
2 Tammi 5min
Tesla Rises Ahead of Deliveries Report; Baidu Soars; Furniture Companies Move Higher
On this episode of Stock Movers:- Shares of Tesla (TSLA) are outperforming Magnificent Seven shares in premarket trading ahead of the electric-car maker’s fourth-quarter production and deliveries repo...
2 Tammi 4min
BE Semiconductor Up, Orsted Rises, BAT Down
On This episode of Stock Movers:- Orsted filed a legal complaint after the Trump administration suspended the lease of a wind project that’s near completion off Rhode Island. Orsted rose as much as 3....
2 Tammi 5min
Vestas Gains, Munters Rises, BAT Down
On This episode of Stock Movers:- Vestas gains as much as 4%, reaching the highest since June 2024, as JPMorgan says the firm is set to deliver orders above expectations in the fourth quarter, support...
2 Tammi 4min
Nike, Trump Media End Day Higher; Corcept Plunges
On this episode of Stock Movers: - Nike (NKE) shares end the day higher after CEO Elliott Hill reported the purchase of about $1 million in shares. Last week, Apple CEO and Nike board member Tim Cook ...
31 Joulu 20256min
Nike, DJT Rise; Corcept Falls
On this episode of stock movers: Nike (NKE) shares rose on Wednesday after CEO Elliott Hill reported the purchase of about $1 million in shares. Corcept (CORT) shares fell after US regulators rejecte...
31 Joulu 20254min
Vanda Pharmaceuticals Up, Nike Gains, Biggest Winners of 2025
On this episode of Stock Movers:- Vanda Pharmaceuticals (VNDA) shares soar as much as 24% in premarket trading on Wednesday after the biopharmaceutical company said the US FDA has approved Nereus (tra...
31 Joulu 20254min
